Update from CredibleMeds for LQT patients

Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/.

We have recently received the following message through CredibleMeds:

September 10, 2020

Addition of six drugs to the QTdrugs categories
We are writing to inform you that the following four drugs have been added to the category of drugs with a Possible Risk of Torsades de Pointes (TdP):

  • Levetiracetam, a drug for the treatment of epilepsy
  • Ozanimod, a drug used to treat multiple sclerosis
  • Remimazolam, a sedative
  • Oliceridine, an opioid used to treat pain

Also, another drug used to treat parasitic infections, Meglumine antimoniate, has been added to the Known Risk of TdP category, and the decongestant, Levmetamphetamine, has been added to the list of Drugs to be Avoided by patients with congenital long QT. 

More to explorer

National myheart meeting-16th March,2024

A myheart members’ meeting was held at Friends House, 173-177 Euston Road, London NW1 2BJ, between 2pm-5pm on Saturday 16th March 2024. Please

WhatsApp
Facebook
Twitter
Reddit
Email
Skip to content